Results 11 to 20 of about 18,247 (232)

Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma

open access: yesBMC Gastroenterology, 2008
Background Studies on gastrointestinal symptoms, dysfunctions, and neurological disorders in systemic scleroderma are lacking so far. Methods Thirty-eight scleroderma patients (34 limited, 4 diffuse), 60 healthy controls and 68 dyspeptic controls were ...
Palasciano Giuseppe   +6 more
doaj   +2 more sources

Atypical rapid onset Scleroderma Renal Crisis (SRC) complicated with diffuse alveolar hemorrhage and pleuro-pericardial effusions in a patient with recently diagnosed breast cancer and a positive anti-RNA polymerase III Ab.: A case report

open access: yesRespiratory Medicine Case Reports, 2018
Scleroderma associated Pulmonary–Renal Syndrome is a rare but severe complication with a poor prognosis and high mortality. A high index of suspicion is needed for early recognition of this potential complication in patients with systemic sclerosis and ...
Hazim Bukamur   +5 more
doaj   +2 more sources

Localized scleroderma: A rare clinical entity

open access: yesJournal of Indian Academy of Oral Medicine and Radiology, 2014
Localized Scleroderma (LS), which is also referred to as morphea, is an inflammatory disease that leads to diffuse or localized fibrotic and atrophic skin hardening.
Ranjana Garg   +2 more
doaj   +2 more sources

Refractory scleroderma renal crisis precipitated after high-dose oral corticosteroids and concurrent intravitreal injection of bevacizumab [PDF]

open access: yesSAGE Open Medical Case Reports, 2020
Scleroderma renal crisis is a serious complication that can develop in certain patients with systemic sclerosis. Some risks have been identified as potential triggers of scleroderma renal crisis, including the high-dose oral corticosteroids.
Ramy M Hanna   +9 more
doaj   +2 more sources

Prospects for using mycophenolate mofetil in diffuse scleroderma

open access: yesСовременная ревматология, 2009
The paper considers the immunosuppressive properties of micophenolate mofetil (MMF) and results of its use in graft rejection and rheumatic diseases. It also provides evidence suggesting the suppression of overfibrosis with the use of MMF, as well as the
L P Ananyeva
doaj   +3 more sources

Systemic sclerosis (Scleroderma) Among Adults Attending the Rheumatology Clinic of a Tertiary Institution

open access: yesAnnals of Health Research, 2016
Background: Systemic sclerosis is a multi-systemic autoimmune disorder characterised by the generation of autoantibodies, massive deposition of collagen and other matrix substances in the connective tissues and alterations of the microvasculature ...
Oguntona SA, Olatunde OA, Bakare BO
doaj   +2 more sources

Acute diffuse scleroderma

open access: yesActa Dermato-Venereologica, 1981
A case of acute diffuse scleroderma without contemporaneous visceral involvement is described. Antibodies to endothelial cells have been found in the skin.
E, Nunzi, A, Rebora, R H, Cormane
openaire   +2 more sources

Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy [PDF]

open access: yes, 2011
The aim of this study was to determine, through a genome-wide association study (GWAS), the genetic components contributing to different clinical sub-phenotypes of systemic sclerosis (SSc).
Kreuter, A   +607 more
core   +1 more source

Experience of successful autologous hematopoietic stem cell transplantation in patients with an unfavorable prognosis of systemic scleroderma

open access: yesНаучно-практическая ревматология, 2022
One of the methods of treating severe forms of systemic scleroderma is hematopoietic stem-cell autotransplantation (auto-HSCT). The article describes two clinical cases of auto-HSCT followed by rituximab (RTM) therapy in patients with diffuse systemic ...
V. I. Mazurov   +8 more
doaj   +1 more source

Functional evaluation of patients with progressive systemic sclerosis-associated diffuse parenchymal lung disease

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2019
Background Interstitial lung diseases are common features in scleroderma that seem to add to the morbidity and mortality of the disease. Other complications that may occur with scleroderma are pulmonary hypertension. Aim to evaluate the functional status
Ahmed A.A Hussieny   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy